Purdue Settles OxyContin Patent Cases Against KV
Purdue Pharma LP has resolved patent infringement litigation against specialty pharmaceutical firm KV Pharmaceutical Co. and agreed to permit KV to launch generic versions of painkiller OxyContin for a limited time...To view the full article, register now.
Already a subscriber? Click here to view full article